Ospedale Policlinico San Martino
🇮🇹Italy
- Country
- 🇮🇹Italy
- Ownership
- Private
- Established
- 1923-01-01
- Employees
- 1K
- Market Cap
- -
Evaluation of the Beneficial Effects of a Product Containing Γ-aminobutyric Acid (GABA) on Climacteric Syndrome Disorders
Not Applicable
Recruiting
- Conditions
- Climacteric SymptomsHot Flashes
- First Posted Date
- 2025-03-07
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Ospedale Policlinico San Martino
- Target Recruit Count
- 112
- Registration Number
- NCT06864520
- Locations
- 🇮🇹
Ospedale San Martino, Genova, Italia, Italy
PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Ospedale Policlinico San Martino
- Target Recruit Count
- 400
- Registration Number
- NCT06809673
- Locations
- 🇮🇹
IRCCS Policlinico San Martino, Genoa, Italy
Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers
Phase 1
Completed
- Conditions
- Diabetic Foot UlcerSkin LesionsAllogeneicPRP
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Ospedale Policlinico San Martino
- Target Recruit Count
- 72
- Registration Number
- NCT06680856
- Locations
- 🇮🇹
IRCCS Ospedale San Martino, Genova, GE, Italy
🇮🇹Istituto dermatopatico dell'Immacolata, Roma, Italy
ENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer Patients
Recruiting
- Conditions
- Cognitive Side Effects of Cancer TherapyHypoestrogenism
- Interventions
- Diagnostic Test: validated questionnairesDiagnostic Test: functional MRIDiagnostic Test: Optical Coherent Tomography Angiography
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2024-09-23
- Lead Sponsor
- Ospedale Policlinico San Martino
- Target Recruit Count
- 60
- Registration Number
- NCT06606535
- Locations
- 🇮🇹
IRCCS Ospedale Policlinico San Martino, Genova, GE, Italy
Endovascular vs Conservative Treatment in Patients With Chronic Subdural Hematomas and Mild Symptoms
Not Applicable
Not yet recruiting
- Conditions
- Subdural Hematoma, Chronic
- Interventions
- Device: embolization of the middle meningeal artery
- First Posted Date
- 2024-02-23
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Ospedale Policlinico San Martino
- Target Recruit Count
- 300
- Registration Number
- NCT06274580
A run-in Study on the Safety and Tolerability of a Fasting Mimicking Diet in Relapsing Remitting Multiple Sclerosis
Early Phase 1
Active, not recruiting
- Conditions
- Multiple Sclerosis
- Interventions
- Dietary Supplement: 7-day Fasting-Mimicking Diet (7-DAY FMD)
- First Posted Date
- 2023-09-15
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- Ospedale Policlinico San Martino
- Target Recruit Count
- 24
- Registration Number
- NCT06039007
- Locations
- 🇮🇹
Ospedale San Martino, Genova, Italy
Osmotin Plant Protein for Progressive Multiple Sclerosis
Not Applicable
Recruiting
- Conditions
- Progressive Multiple Sclerosis
- Interventions
- Dietary Supplement: Osmotin
- First Posted Date
- 2023-07-10
- Last Posted Date
- 2023-07-10
- Lead Sponsor
- Ospedale Policlinico San Martino
- Target Recruit Count
- 50
- Registration Number
- NCT05937802
- Locations
- 🇮🇹
Azienda Ospedaliera Universitaria Sant'Andrea, Roma, Italy
🇮🇹IRCCS Ospedale Policlinico San Martino, Genova, Italy
Study for the Development and Validation of Chronic Cough Patient Perspective Questionnaire
Completed
- Conditions
- Chronic Cough
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Ospedale Policlinico San Martino
- Target Recruit Count
- 150
- Registration Number
- NCT05642559
- Locations
- 🇮🇹
IRCCS San Martino, Genova, Italy
Niraparib Maintenance Treatment in mCRC With a Partial o Complete Response After Oxaliplatin-based Induction Therapy
- First Posted Date
- 2022-06-09
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- Ospedale Policlinico San Martino
- Registration Number
- NCT05412706
Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial
Phase 2
Recruiting
- Conditions
- Colorectal Cancer Stage IVNo Evidence of Disease State
- Interventions
- First Posted Date
- 2022-05-19
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Ospedale Policlinico San Martino
- Target Recruit Count
- 182
- Registration Number
- NCT05382741
- Locations
- 🇮🇹
IRCCS Ospedale Policlinico San Martino, Genova, Liguria, Italy
© Copyright 2025. All Rights Reserved by MedPath